Various regions within the alpha‐helical domain of the COL1A1 gene are fused to the second exon of the PDGFB gene in dermatofibrosarcomas and giant‐cell fibroblastomas

Dermatofibrosarcoma protuberans (DFSP) and its juvenile form, giant‐cell fibroblastoma (GCF), are uncommon infiltrative tumors of the dermis, which present unique cytogenetic features, such as the reciprocal translocation t(17;22) or, more commonly, supernumerary ring chromosomes containing sequences from chromosomes 17 and 22. We have recently shown that these aberrations are cytogenetic manifestations of gene fusions between the platelet‐derived growth factor B‐chain gene (PDGFB), the cellular equivalent of the v‐sis oncogene, and the collagen type I alpha 1 gene (COL1A1), the major protein constituent of the extracellular matrix in connective tissue of skin. We now report characterization of COL1A1/PDGFB chimeric genes at the RNA and DNA sequence levels in a series of DFSPs and GCFs. All 16 tumors studied contained the COL1A1/PDGFB gene. The location of breakpoints within COL1A1 varied greatly, but was always limited to the region encoding the alpha‐helical domain. The PDGFB segment of the chimeric transcript always starts with exon 2, placing PDGFB under the control of the COL1A1 promoter and removing all known elements negatively controlling PDGFB transcription and translation. Production of these aberrant transcripts in fibroblasts, the suspected cell of origin of DFSP/GCF, likely causes autocrine stimulation and cell proliferation. No specific function has yet been assigned to exon 2 of PDGFB, and this exon does not encode for the mature growth factor. Its retention in all chimeric COL1A1/PDGFB genes suggests that it is important for the normal processing of the PDGFB polypeptide. Genes Chromosomes Cancer 23:187–193, 1998. © 1998 Wiley‐Liss, Inc.

[1]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[2]  E. Blennow,et al.  The germinal center kinase gene and a novel CDC25-like gene are located in the vicinity of the PYGM gene on 11q13 , 1997, Human Genetics.

[3]  P. van Eyken,et al.  Anomalies of chromosomes 17 and 22 in giant cell fibroblastoma. , 1997, Cancer genetics and cytogenetics.

[4]  B. Johansson,et al.  A breakpoint map of recurrent chromosomal rearrangements in human neoplasia , 1997, Nature Genetics.

[5]  D. Birnbaum,et al.  Identification of a YAC spanning the translocation breakpoint t(8;22) associated with acute monocytic leukemia , 1996, Genes, chromosomes & cancer.

[6]  F. Fish Soft Tissue Sarcomas in Dermatology , 1996, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[7]  P. Cin,et al.  Cytogenetic and immunohistochemical evidence that giant cell fibroblastoma is related to dermatofibrosarcoma protuberans , 1996, Genes, chromosomes & cancer.

[8]  F. Hecht,et al.  Ring 22 chromosomes in dermatofibrosarcoma protuberans are low-level amplifiers of chromosome 17 and 22 sequences. , 1995, Cancer research.

[9]  H. Correa,et al.  Aggressive giant cell fibroblastoma with a balanced 17;22 translocation. , 1995, Cancer genetics and cytogenetics.

[10]  Todd R. Golub,et al.  Fusion of PDGF receptor β to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation , 1994, Cell.

[11]  M. Fujimoto,et al.  Dermatofibrosarcoma protuberans: increased growth response to platelet-derived growth factor BB in cell culture. , 1993, Biochemical and biophysical research communications.

[12]  R. Dirks,et al.  DNase-I-hypersensitive sites located far upstream of the human c-sis/PDGF-B gene comap with transcriptional enhancers and a silencer and are preceded by (part of) a new transcription unit. , 1993, European journal of biochemistry.

[13]  J. Coindre,et al.  Ring chromosomes in dermatofibrosarcoma protuberans contain chromosome 17 sequences: fluorescence in situ hybridization. , 1993, Cancer genetics and cytogenetics.

[14]  W. Chan,et al.  Acute megakaryoblastic leukemia in infants with t(1;22)(p13;q13) abnormality. , 1992, American journal of clinical pathology.

[15]  E. Rutgers,et al.  Dermatofibrosarcoma protuberans: treatment and prognosis. , 1992, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[16]  F. Ekenstam,et al.  Expression of platelet-derived growth factor and its receptors in proliferative disorders of fibroblastic origin. , 1992, The American journal of pathology.

[17]  A. Olsen,et al.  Completion of the last half of the structure of the human gene for the Pro alpha 1 (I) chain of type I procollagen (COL1A1). , 1991, Matrix.

[18]  R. Jaenisch,et al.  Structure of a full-length cDNA clone for the prepro alpha 1(I) chain of human type I procollagen. , 1988, The Biochemical journal.

[19]  S. Aaronson,et al.  The 5' untranslated sequence of the c-sis/platelet-derived growth factor 2 transcript is a potent translational inhibitor , 1988, Molecular and cellular biology.

[20]  P. Chomczyński,et al.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.

[21]  R. Ross,et al.  The biology of platelet-derived growth factor , 1986, Cell.

[22]  R F Doolittle,et al.  Simian sarcoma virus onc gene, v-sis, is derived from the gene (or genes) encoding a platelet-derived growth factor. , 1983, Science.

[23]  Paul Stroobant,et al.  Platelet-derived growth factor is structurally related to the putative transforming protein p28sis of simian sarcoma virus , 1983, Nature.

[24]  E. Reddy,et al.  Nucleotide sequence of the simian sarcoma virus genome: demonstration that its acquired cellular sequences encode the transforming gene product p28sis. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[25]  Raymond Dalgleish,et al.  The human type I collagen mutation database , 1997, Nucleic Acids Res..

[26]  J. Dumanski,et al.  Deregulation of the platelet-derived growth factor β-chain gene via fusion with collagen gene COL1A1 in dermatof ibrosarcoma protuberans and giant-cell fibroblastoma , 1997, Nature Genetics.

[27]  G. Sozzi,et al.  Translocation, t(17;22)(q22;q13), in dermatofibrosarcoma protuberans: a new tumor-associated chromosome rearrangement. , 1996, Cytogenetics and cell genetics.

[28]  J. Fletcher,et al.  Ring chromosomes in dermatofibrosarcoma protuberans are composed of interspersed sequences from chromosomes 17 and 22. , 1995, The American journal of pathology.

[29]  G. Karsenty,et al.  Regulation of type I collagen genes expression. , 1995, International reviews of immunology.

[30]  N. Iscove,et al.  Overexpression of PDGF-B in murine hematopoietic cells induces a lethal myeloproliferative syndrome in vivo. , 1994, Oncogene.

[31]  P. Byers,et al.  Brittle bones--fragile molecules: disorders of collagen gene structure and expression. , 1990, Trends in genetics : TIG.

[32]  S. Robbins,et al.  Pathologic basis of disease , 1974 .